Status:
COMPLETED
Short-pulse Subthreshold vs Infrared Micropulse for Diabetic Macular Edema
Lead Sponsor:
Moorfields Eye Hospital Centre Abu Dhabi
Collaborating Sponsors:
King Khaled Eye Specialist Hospital
University of Nebraska
Conditions:
Diabetic Macular Edema
Eligibility:
All Genders
18-70 years
Phase:
NA
Brief Summary
When applied according to manufacturer recommendations, short-pulse system may yield more temporary reduction in edema while infrared micropulse system may yield slightly better functional outcomes.
Detailed Description
Purpose: To assess both anatomic and functional outcomes between short-pulse continuous wavelength and infrared micropulse lasers in the treatment of DME. Materials and Methods: A prospective interve...
Eligibility Criteria
Inclusion
- center-involving clinically significant macular edema due to diabetic retinopathy (\>300 microns)
- clear ocular media
- ETDRS visual acuity \>29 letters (Snellen equivalent of 20/150) or better
- treatment naïve eyes or previously treated with antiangiogenic intravitreal agent(s) more than 6 months ago to allow for long wash-out period
Exclusion
- non-center involving diabetic macular edema
- previous retinal laser or surgery
- intravitreal steroid use
- any condition that may be associated with a risk of macular edema such as age-related macular degeneration, retinal vein occlusion, vitreomacular traction, epiretinal membrane and others.
Key Trial Info
Start Date :
January 1 2015
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2017
Estimated Enrollment :
113 Patients enrolled
Trial Details
Trial ID
NCT04505306
Start Date
January 1 2015
End Date
January 1 2017
Last Update
August 10 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Moorfields Eye Hospital Centre
Abu Dhabi, United Arab Emirates